Aenova boosts effervescent tablet capacity to 500m
The Aenova Group is switching production of effervescent tablets used for food supplements and pharmaceuticals from Switzerland to Germany to boost annual production potential to 500m.
The Aenova Group is switching production of effervescent tablets used for food supplements and pharmaceuticals from Switzerland to Germany to boost annual production potential to 500m.
Part of the reasoning for Unilever’s controversial 2008 decision to sever a €20m partnership with UK firm Phytopharm to develop the weight management plant hoodia gordonii has become apparent, with disappointing trial results published this month.
An International Dairy Federation taskforce has updated a 2002 inventory of safe microbial species including some probiotic species – from 112 to 221 – a list the group hopes will allow exemption from EU Novel Foods and US New Dietary Ingredient (NDI)...
Dispatches from SupplySide West 2011
The omega-3 market needs the new entrants from algae, but the new sources need to be manageable and scalable to ensure success, says the VP of business development for Aurora Algae.
The functionality of the New Dietary Ingredient (NDI) guidance can be improved in only six steps, says direct selling giant Herbalife in its comments to the US Food and Drug Administration (FDA).
It is now increasingly likely that a judgment in the Federal Trade Commission’s (FTC’s) false advertising case against POM Wonderful will not be issued before POM squares up with rival Ocean Spray next month at a trial the cranberry juice giant has...
The European Food Safety Authority (EFSA) has published draft guidance on neurological and psychological health claim submissions – and has given stakeholders until December 16 to submit comments.